{"disease":{"id":"moderate-aortic-valve-stenosis","name":"moderate aortic valve stenosis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07001800","title":"Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":1276,"lead_sponsor_name":"Kardigan, Inc.","has_results":false},{"nct_id":"NCT06168123","title":"Future Optimal Research and Care Evaluation - Aortic Stenosis","phase":"","overall_status":"RECRUITING","enrollment_count":800,"lead_sponsor_name":"St. Antonius Hospital","has_results":false},{"nct_id":"NCT07532317","title":"A Prospective, Multinational, Multicentre, Open-label, Randomized Trial to Evaluatesafety and Effectiveness of Meril's Myval Transcatheter Heart Valve (THV) Series Compared toGuideline-Directed Medical Therapy (GDMT) in Participants With Moderate Aortic Stenosis.","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":778,"lead_sponsor_name":"Meril Life Sciences Pvt. Ltd.","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}